期刊
FASEB JOURNAL
卷 23, 期 10, 页码 3383-3392出版社
FEDERATION AMER SOC EXP BIOL
DOI: 10.1096/fj.09-134296
关键词
Alzheimer; Down syndrome; DSCR1
资金
- National Natural Science Foundation of China [NSFC 30771075]
- Taishan Scholarship
- Canadian Institutes of Health Research (CIHR)
- Jack Brown and Family Alzheimer's Research Foundation
- Michael Smith Foundation for Health Research (MSFHR)
- Canada Research Chair in Alzheimer's Disease
Regulator of calcineurin 1 (RCAN1), a gene identified from the critical region of Down syndrome, has been implied in pathogenesis of Alzheimer's disease ( AD). RCAN1 expression was shown to be increased in AD brains; however, the mechanism of RCAN1 gene regulation is not well defined. The present study was designed to investigate the molecular mechanism of RCAN1 protein degradation. In addition to being degraded through the ubiquitin proteasome pathway, we found that lysosomal inhibition markedly increased RCAN1 protein expression in a time- and dosage-dependent manner. Inhibition of macroautophagy reduced RCAN1 expression, indicating that RCAN1 degradation is not through a macroautophagy pathway. However, disruption of chaperone-mediated autophagy (CMA) increased RCAN1 expression. Two CMA recognition motifs were indentified in RCAN1 protein to mediate its degradation through a CMA-lysosome pathway. A promoter assay further demonstrated that inhibition of RCAN1 degradation in cells reduced calcineurin-NFAT activity. Dysfunctions of ubiquitin-proteasome and autophagy-lysosome pathways have been implicated in neurodegenerative diseases. Therefore, elucidation of RCAN1 degradation by a ubiquitin proteasome pathway and CMA-lysosome pathway in the present study may greatly advance our understanding of AD pathogenesis.-Liu, H., Wang, P., Song, W., Sun, X. Degradation of regulator of calcineurin 1 ( RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways. FASEB J. 23, 3383-3392 ( 2009). www.fasebj.org
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据